The regulatory landscape is evolving: in February 2026, HHS announced that approximately 14 previously restricted peptides including BPC-157, TB-500, CJC-1295, Ipamorelin, and Sermorelin are expected to return to Category 1 compounding status
others have prolonged dysbiosis-like symptoms
The enhanced metabolic efficiency and improved sleep quality create a sustained baseline that feels fundamentally different from your pre-protocol state
Run GHK-Cu alone for at least 12 weeks
FDA Commissioner Marty Makary vowed swift action against companies mass-marketing illegal copycat drugs, claiming they are similar to FDA-approved products. The FDA cannot verify the quality, safety or effectiveness of non-approved drugs, he shared in a social media post
It is obesity-specific: six days of long-acting glucagon raised energy expenditure in diet-induced obese mice and had no effect in lean mice